CiteAb Names Cell Signaling Technology, “Antibody Company of the Year” and “Researchers’ Choice”
Cell Signaling Technology (CST), a leading provider of antibodies, kits and services, was honored with the 2016 CiteAb Award for “Researchers’ Choice” and for a second year in a row with the award for “Antibody Company of the Year.” Now in its second year, the CiteAb Antibody Awards aim to celebrate the very best suppliers, reagents and individuals in the research antibody sector, recognizing the efforts that are made to progress science.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160211005303/en/
Andrew Chalmers, Ph.D., founder of CiteAb, said: "The level of competition in the awards this year was very strong, so Cell Signaling Technology has done extremely well to have won in two categories. They received some glowing nominations for the researchers' choice award. At CiteAb we're looking forward to seeing the company develop and grow, and we wish the team at Cell Signaling many congratulations for their awards."
“As a company of scientists, we are humbled and honored to have our efforts recognized by the research community with these two awards. We know customers have a choice when it comes to their antibody supplier and we aim to stand apart through our rigorous development and validation processes and full-service technical support. These awards reinforce to us that the community at large values these efforts,” said Michael J. Comb, Ph.D., Cell Signaling Technology President and CEO.
CiteAb is the largest citation-ranked antibody search engine and database. It provides an impartial way to find and compare antibodies that work.
Cell Signaling Technology (CST) is a private, family-owned company, founded by scientists and dedicated to providing the world’s highest quality, innovative, research and diagnostic products to accelerate biological understanding and enable personalized medicine. Our employees operate worldwide from our U.S. headquarters in Massachusetts, and our offices in the Netherlands, China, and Japan.
Cell Signaling Technology® , and CST™ are trademarks of Cell Signaling Technology, Inc.
Cell Signaling Technology, Inc.
Rebecca J. Reppucci, MBA, 978-867-2382
Director of Marketing Communications
Katrina Kelly, 07403 668718
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
PATIENT-SAFETY-MOVEMENT24.2.2018 11:02 | pressemeddelelse
The 6th Annual World Patient Safety, Science & Technology Summit Kicked off with an Important Announcement about the Progress Being Made to Save Lives in Hospital Settings
CCWW24.2.2018 10:08 | pressemeddelelse
WuQi Technologies is Latest Licensee of CCww’s NB-IoT UE Protocol-Stack Software
IDEMIA23.2.2018 16:59 | pressemeddelelse
IDEMIA and Octo Telematics Reinvent Car Sharing Experience by Adding Facial Recognition to EasyOpen Solution
SM-OPTICS23.2.2018 15:02 | pressemeddelelse
SM-Optics Unveils First FLEXSET Chip, Paving the Way to Optical Micro Nodes
TX-HASHGAINS23.2.2018 14:58 | pressemeddelelse
Bitcoin Miner HashGains’ Crowdsale to Build Green Cloud Mining Data Centers Receives Excellent Response
CARDINALITY23.2.2018 14:09 | pressemeddelelse
Stratecast Recognizes CARDINALITY as a “10 to Watch in 2018”
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum